PACTR201808699550182已完成4 期
Monobenzyl Ether of Hydroquinone (MBEH) 20% and 40% Cream in Depigmentation of Vitiligo Patients: Randomized controlled trial.
Vitiligo unit Dermatology department Cairo university0 个研究点目标入组 40 人开始时间: 2018年8月31日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 13 Year(s) 至 18 Year(s)（—）
- 性别
- All
入选标准
- •?Age above 12 years, both sexes.
- •?Vitiligo patients with >50% body surface area (BSA) involvement retaining few small areas of normal color on face and/or hands.
- •?Vitiligo patients with <50% BSA involvement who are refractory to treatment and aspire at improving aesthetically on face and/or hands.
排除标准
- •?Segmental Vitiligo.
- •?Vitiligo responsive to treatment.
- •?Pregnant or breastfeeding women.
- •?Known allergy to MBEH.
- •?Hepatic or renal diseases.
- •?Concomitant oral corticosteroid or immunosuppressive therapy.
研究者
相似试验
已完成
4 期
Antimicrobial disc (AMD) infection prevention in central venous cathetersCentral-line associated bloodstream infectionInfection - Studies of infection and infectious agentsACTRN12619000918123Griffith University80
招募中
1 期
Hyoscine-N-Butylbromide for the shortening of the Active Phase of Labour in Primigravidae: A Double Blind Randomized Placebo Controlled Trial at the University Of Uyo Teaching Hospital, Akwa-Ibom State, NigeriaPregnancy and ChildbirthPACTR202111520130772DR ANIEKAN JACKSO100
已完成
4 期
se of Halometasone in skin diseases caused by occupational exposure to different agents.CTRI/2014/08/004876SELF150
已完成
不适用
ß-Hydroxy-ß-Methylbutrate (HMB) supplementation and functiOnal OutcomeS in multi-Trauma patients (BOOST TRIAL)Multi-traumaCritical IllnessInjuries and Accidents - Other injuries and accidentsACTRN12620001305910The Royal Melbourne Hospital51
尚未招募
不适用
Progress of labour with hyoscine-n-butyl bromide: a randomized double-blind placebo-controlled studyPACTR201908521430230Fagbohun172